Aug 30 (Reuters) - Blood-testing firm Theranos Inc withdrew
its request for emergency clearance of a Zika-virus blood test
after U.S. regulators found the company did not include proper
patient safeguards in a study on the test, The Wall Street
Journal reported, citing people familiar with the matter.
Read more
No comments:
Post a Comment